内部人交易雷达

美国 · SEC Form 4 · 快照日期： 2026-10-19 · 构建时间： 2026-10-19 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

NEOGEN CORP

NEOG · Nasdaq · CIK 0000711377 · Healthcare · Medical Devices

内部人信号

40.2 / 100

1 位买方 · 2 条买入交易行 · $10.4K 买入总额

为什么有这个信号？

买方广度较低
买入规模较低
角色中等
近期性较强
确信度较强
评分构成

每条进度条表示其对当前分数的贡献；权重和公式保持不变。

Cluster+7.0 / 35
买入规模+1.8 / 25
角色+13.0 / 20
近期性+8.5 / 10
确信度+10.0 / 10

哪些因素限制了当前分数？

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ 角色得分低 · 买入者中职位最高的是：CEO（CEO、董事长和持股 10% 以上的股东得分最低）
  • ✓ Recent activity · latest purchase 2026-10-09

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。

买方广度与集中度

合资格买方1
买入集中度100%最大买方： Nassif Mikheal · $10.4K
聚集买入 · 15天1 insider峰值活动： 2026-08-04–2026-08-04

Roles in the peak window: CEO. Concentration uses priced qualifying P lines only and does not change the saved score.

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。

AprMayJunJulAugSepOct
Moylan John PatrickChief Accounting Officer
○○○○○
Nassif MikhealCEO
●○○●
Stacey Jennifer EvansChief Legal Officer
○○
Rocklin Amy MFormer Chief Legal Officer
○○
Wainer Andrea FDirector
○
RODRIGUEZ RAFAEL ADirector
○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 8 additional owner(s) remain in Form 4 申报证据.

信号历史

40.2 / 100

最新留档分数

↓ -0.2 pts相对上一个留档快照
  1. 41.0
  2. 40.8
  3. 40.7
  4. 40.4
  5. 40.2

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

近期 Form 4 活动

7买入
0卖出
53其他 Form 4 交易行
52SEC 申报 · 365天
买入2 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他21 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息，不影响内部人信号。

价格表现

1M
-2.2%
3M
+19.5%
6M
+32.8%
12M
+107.6%

波动率与流动性

波动率
62.0%
Beta
—
平均每日成交额
USD 39.2M

估值

市值
USD 2.7B
P/E
—

基本面

利润率
-0.9%
ROE
-0.4%
细分行业
Medical Devices

市场数据

价格数据截至：2026-10-15 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值, 利润率, ROE · 财年截止日：2026-05-31 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-31 · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。

空头股数
11,846,307
上期报告
11,168,684
日均成交量
5,825,645
回补天数
2.0

FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2026-10-09Nassif Mikheal买入 (P)Common Stock505USD 11.95USD 6,035SEC 申报 ↗
2026-08-04Nassif Mikheal买入 (P)Common Stock370USD 11.81USD 4,370SEC 申报 ↗
2026-02-17Nassif Mikheal买入 (P)Common Stock23USD 10.94USD 252SEC 申报 ↗
2026-02-02Nassif Mikheal买入 (P)Common Stock24USD 10.00USD 240SEC 申报 ↗
2026-01-26Nassif Mikheal买入 (P)Common Stock25USD 9.86USD 246SEC 申报 ↗
2026-01-16Nassif Mikheal买入 (P)Common Shares137USD 9.33USD 1,278SEC 申报 ↗
2025-11-03Nassif Mikheal买入 (P)Common Shares177USD 6.25USD 1,106SEC 申报 ↗
2025-05-12Gupta Aashima买入 (P)Common Stock16,000USD 6.25USD 100,000SEC 申报 ↗
2025-04-25Woteki Catherine E买入 (P)Common Stock5,770USD 5.17USD 29,831SEC 申报 ↗
2025-04-24BOREL JAMES C买入 (P)Common Stock30,000USD 4.99USD 149,700SEC 申报 ↗
2025-04-24BOREL JAMES C买入 (P)Common Stock35,000USD 4.89USD 171,150SEC 申报 ↗
2025-04-24BOEHM WILLIAM T买入 (P)Common Stock5,000USD 5.24USD 26,200SEC 申报 ↗
2025-04-23Rocklin Amy M买入 (P)Common Stock12,500USD 4.99USD 62,375SEC 申报 ↗
2025-04-22Tobin James P买入 (P)Common Stock10,000USD 4.73USD 47,300SEC 申报 ↗
2025-04-22RODRIGUEZ RAFAEL A买入 (P)Common Stock7,474USD 4.59USD 34,306SEC 申报 ↗

Form 4 申报证据

60 transaction lines in the latest 365-day window; 340 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-10-09Nassif Mikheal买入 (P)Common Stock505USD 11.95USD 6,035SEC 申报 ↗
2026-10-01Woteki Catherine E奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-10-01Wainer Andrea F奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-10-09Nassif Mikheal买入 (P)Common Stock505USD 11.95USD 6,035SEC 申报 ↗
2026-10-01Woteki Catherine E奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-10-01Wainer Andrea F奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-10-01RODRIGUEZ RAFAEL A奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-10-01Pelossof Avi奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-10-01Gupta Aashima奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-10-01Green Ronald D奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-10-01CAPELLO JEFFREY D奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-10-01BOREL JAMES C奖励／授予 (A)Restricted Stock Units9,804USD 12.24USD 120,001SEC 申报 ↗
2026-08-19Nassif Mikheal代扣税 (F)Restricted Stock Units20,397USD 11.87USD 242,112SEC 申报 ↗
2026-08-19Moylan John Patrick代扣税 (F)Restricted Stock Units2,365USD 11.87USD 28,073SEC 申报 ↗
2026-08-14Stacey Jennifer Evans奖励／授予 (A)Common Stock38,627USD 11.65USD 450,005SEC 申报 ↗
2026-08-14Riggsbee Richard Bryan奖励／授予 (A)Common Stock51,502USD 11.65USD 599,998SEC 申报 ↗
2026-08-14Ranalli Tamara A.奖励／授予 (A)Common Stock25,751USD 11.65USD 299,999SEC 申报 ↗
2026-08-14Nassif Mikheal奖励／授予 (A)Common Stock141,631USD 11.65USD 1,650,001SEC 申报 ↗
2026-08-14Moylan John Patrick奖励／授予 (A)Restricted Stock Units8,584USD 11.65USD 100,004SEC 申报 ↗
2026-08-04Nassif Mikheal买入 (P)Common Stock370USD 11.81USD 4,370SEC 申报 ↗
2026-06-03Moylan John Patrick代扣税 (F)Restricted Stock Units2,553USD 8.75USD 22,339SEC 申报 ↗
2026-05-18Rocklin Amy M期权行权／转换 (M)Common Stock35,183USD 9.29USD 326,850SEC 申报 ↗
2026-05-18Rocklin Amy M代扣税 (F)Common Stock10,241USD 9.29USD 95,139SEC 申报 ↗
2026-05-04Moylan John Patrick期权行权／转换 (M)Common Stock4,558USD 9.53USD 43,438SEC 申报 ↗
2026-05-04Moylan John Patrick代扣税 (F)Common Stock1,568USD 9.53USD 14,943SEC 申报 ↗
2026-05-01Stacey Jennifer Evans奖励／授予 (A)Common Stock39,349USD 9.53USD 374,996SEC 申报 ↗
2026-02-17Nassif Mikheal买入 (P)Common Stock23USD 10.94USD 252SEC 申报 ↗
2026-02-02Nassif Mikheal买入 (P)Common Stock24USD 10.00USD 240SEC 申报 ↗
2026-01-26Nassif Mikheal买入 (P)Common Stock25USD 9.86USD 246SEC 申报 ↗
2026-01-16Nassif Mikheal买入 (P)Common Shares137USD 9.33USD 1,278SEC 申报 ↗
2026-01-07Ranalli Tamara A.奖励／授予 (A)Common Stock50,813USD 7.38USD 375,000SEC 申报 ↗
2026-01-07Ranalli Tamara A.奖励／授予 (A)Common Stock50,813USD 7.38USD 375,000SEC 申报 ↗
2025-12-01Naemura David H.期权行权／转换 (M)Common Stock12,912USD 5.98USD 77,214SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-19
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码NEOG
CIK0000711377
行业Healthcare
细分行业Medical Devices Yahoo Finance
SEC SIC2835 In Vitro & In Vivo Diagnostic Substances
交易所Nasdaq

数据覆盖

本地 Form 4 历史340 transaction lines from 2020-01-06 to 2026-10-09
44 P purchase lines · 58 S sale lines · 238 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.